유비케어
Financials
Valuation Metrics
유비케어's Market Cap is ₩1587B. At end of 2025 it was ₩1905B. Ranked #931 of 2,405 in KR market (top 39%), #444 of 1,627 on KOSDAQ (top 27%), #30 of 94 in Health Care Equipment & Services (top 32%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 158.68B KRW | KR#931/2,405 Sec#30/94 |
| Revenue | 205.08B KRW | KR#1,016/2,405 Sec#12/94 |
| Net Income | -569.9M KRW | KR—/2,405 Sec—/94 |
| Total Assets | 230.58B KRW | KR#1,213/2,405 Sec#32/94 |
| Net Assets | 160.44B KRW | KR#1,094/2,405 Sec#30/94 |
| Employees | 338 | KR#708/2,405 Sec#18/94 |
| Value | ||
| P/B | 0.99x | KR#1,529/2,405 Sec#44/94 |
| P/S | 0.77x | KR#1,267/2,405 Sec#20/94 |
| EV/EBITDA | 12.51x | KR#793/2,405 Sec#27/94 |
| Profitability | ||
| ROE | -0.36% | KR#1,570/2,405 Sec#50/94 |
| ROA | -0.25% | KR#1,579/2,405 Sec#51/94 |
| Op. Margin | 5.94% | KR#839/2,405 Sec#37/94 |
| Revenue Growth | 6.53% | KR#1,098/2,405 Sec#61/94 |
| Earnings Growth | -101.40% | KR#1,146/2,405 Sec#39/94 |
| Financial Health | ||
| Debt Ratio | 43.71% | KR#857/2,405 Sec#45/94 |
| Total Debt | 7.34B KRW | KR#1,707/2,405 Sec#56/94 |
| Cash | 13.67B KRW | KR#1,492/2,405 Sec#45/94 |
| Current Ratio | 1.89x | KR#919/2,405 Sec#55/94 |
| Net Debt/EBITDA | -0.52x | KR#485/2,405 Sec#20/94 |
| Dividend | ||
| Div. Yield | 1.65% | KR#999/2,405 Sec#28/94 |
| Div. Growth | 66.67% | KR#178/2,405 Sec#10/94 |
| Performance | ||
| 1Y Return | -14.97% | KR#989/2,405 Sec#28/94 |
| 1M Return | -5.88% | KR#791/2,405 Sec#27/94 |
| From 52W High | -30.75% | KR#434/2,405 Sec#10/94 |
| 1Y MDD | -38.11% | KR#495/2,405 Sec#14/94 |
| Trading | ||
| Volume | 159,520 shares | KR#454/2,405 Sec#17/94 |
| Trading Value | 472.7M KRW | KR#821/2,405 Sec#23/94 |
| Foreign Own. | 2.08% | KR#1,592/2,405 Sec#58/94 |
| Per Share | ||
| EPS | -11 KRW | KR—/2,405 Sec—/94 |
| BPS | 3,074 KRW | KR#1,855/2,405 Sec#59/94 |
Company Info
Established in 1994 and listed on KOSDAQ in 1997, this company developed Korea's first EMR (Electronic Medical Record) system. It boasts a network of approximately 26,000 medical institutions nationwide, offering EMR solution development and supply, healthcare big data analysis, pharmaceutical marketing platform operations, and the distribution and manufacturing of medical consumables, pharmaceuticals, and equipment. The company also provides patient and silver care platform services, and is currently building an integrated medical platform through services such as 'Ttokktok' for medical consultations, 'Doctorvice' for chronic disease management, and 'Ttohanauigajok' for silver care. Ubicare is headquartered in Seongdong-gu, Seoul Special City.